Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
about
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversyCurrent therapy of myelodysplastic syndromesPre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndromeMyelodysplastic syndromes: toward a risk-adapted treatment approach.Myelodysplastic syndromes in the United States: an update for clinicians.Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy.Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome.
P2860
Q27010653-B6C8FD18-0698-43C8-A7B4-5F166875325AQ34013796-78D8EC4D-853D-4B14-BE72-5D1BA5CB5980Q36544315-2D1FC58A-5DF5-4EF3-961B-4B9AA034B885Q38149315-3ABAD4C7-C2AE-4FCE-B11B-128CE2726023Q38203323-AFAAB46D-B268-42EA-B4BC-906FFD9D9ADAQ38225750-80278435-855E-48EB-82A7-A7A892A6318AQ41359251-0FB62AB0-D96B-47BA-B33D-3CB47DA8CBE6
P2860
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@ast
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@en
type
label
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@ast
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@en
prefLabel
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@ast
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@en
P2860
P1433
P1476
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
@en
P2093
Boglarka Gyurkocza
P2860
P304
P356
10.1016/J.BLRE.2012.08.002
P577
2012-09-13T00:00:00Z